Castleark Management’s Codexis CDXS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-102,750
Closed -$2.12M 312
2022
Q1
$2.12M Sell
102,750
-107,320
-51% -$2.22M 0.09% 185
2021
Q4
$6.57M Sell
210,070
-22,705
-10% -$747K 0.24% 105
2021
Q3
$5.41M Buy
232,775
+64,967
+39% +$1.54M 0.21% 118
2021
Q2
$3.8M Buy
167,808
+23,923
+17% +$518K 0.13% 155
2021
Q1
$3.29M Buy
+143,885
New +$3.37M 0.12% 160
2019
Q2
Sell
-287,454
Closed -$5.9M 358
2019
Q1
$5.9M Sell
287,454
-5,088
-2% -$98.8K 0.22% 147
2018
Q4
$4.88M Sell
292,542
-134,106
-31% -$2.31M 0.21% 146
2018
Q3
$7.32M Sell
426,648
-6,630
-2% -$107K 0.21% 157
2018
Q2
$6.24M Buy
+433,278
New +$5.65M 0.19% 167

Other funds holding CDXS

Castleark Management's CDXS Position: Q2 2022 in Review

Castleark Management sold out of Codexis (CDXS) in Q2 2022, closing a stake of 102,750 shares — an estimated $2.12M sold.

Castleark Management first reported a position in CDXS in Q2 2018 and held it in 9 quarters. The position peaked at $7.32M in Q3 2018. 168 funds tracked by Wall St. Rank hold CDXS as of Q2 2022.

  • Castleark Management reported no remaining Codexis position as of Q2 2022 after selling out during the quarter.
  • Castleark Management sold 102,750 Codexis shares in Q2 2022, an estimated $2.12M.
  • Castleark Management first reported a position in Codexis in Q2 2018 and held it in 9 quarters.
  • Castleark Management's Codexis position peaked at $7.32M in Q3 2018.
  • 168 funds tracked by Wall St. Rank held Codexis as of Q2 2022.

Based on Castleark Management's 13F filing for Q2 2022, filed 16 Aug 2022.